Dataset from A Phase 2, Multicenter, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Intravenous Dose of MEDI-546, a Human Monoclonal Antibody Directed Against Type I Interferon Receptor (IFNAR), in Japanese Subjects With Active Systemic Lupus Erythematosus (SLE).
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008193
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess safety, tolerability, pharmacokinetics and
pharmacodynamics of MEDI-546 in Japanese SLE patients.
创建时间：
2025-07-07
